Sexual Health in the News Week of Feb 14-Feb 20
Feb 20, 2015
NCSH in the News
Other News This Week
Truvada, Gilead's HIV drug, has been approved since 2004 for people with the virus. Taken daily, it can prevent HIV infections 92% of the time, meaning it could drastically reduce new infections in sexually active gay men, among the U.S.'s highest-risk communities.
A new version of the HPV vaccine that fights nine strains of human papillomavirus offered greater cancer protection for women than the earlier one that targets only four.
As gun rights advocates push to legalize firearms on college campuses, an argument is taking shape: Arming female students will help reduce sexual assaults.
A new compound has blocked HIV infection so well in monkeys that it may be able to function as a vaccine against AIDS, the scientists who designed it reported Wednesday.
Most women with private health insurance can get contraception for free, but a lack of information means some are still paying out of pocket-even when they shouldn't be.
To reach young gay men about the need for HIV testing, health advocates are turning to an unconventional messenger: gay dating apps on smartphones.
Aggressive New HIV Virus Strain In Cuba Progresses To AIDS In Less Than 3 Years - Medical Daily
A study has found a new strain of the HIV virus in Cuba with the ability to progress into full-blown AIDS in as little as two to three years.
The drug maker Sprout Pharmaceuticals has resubmitted a new drug application to the FDA for approval of a pill that claims to boost sex drive in premenopausal women.
Media Inquiries
For general media inquiries about sexual health topics and/or to schedule an interview with one of our experts, please contact Susan Gilbert, NCSH Co-Director, at
susan.gilbert@altarum.org